Cyclopropane

Cyclopropane

SCHEMBL247293

C1CC1.N=C=O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopentane SCHEMBL6362858 1.00
SCHEMBL4871564 1.00
Cyclopropane SCHEMBL10596924 1.00
Cyclohexane SCHEMBL11564271 1.00 ALDH1A1 (0.30)
Cyclopentane SCHEMBL661225 1.00 ALDH1A1 (0.30)
Cyclohexane SCHEMBL48514 1.00 ALDH1A1 (0.30)
Cycloheptane SCHEMBL8811487 1.00 ALDH1A1 (0.30)
Cycloheptane SCHEMBL4048765 1.00 ALDH1A1 (0.30)
Cyclopentane SCHEMBL7267488 1.00 ALDH1A1 (0.30)
SCHEMBL890420 1.00 ALDH1A1 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113061337-B Resin composition 财团法人工业技术研究院 2023-05-16 CN claimed
CN-109867954-A Resin combination 财团法人工业技术研究院 2019-06-11 CN claimed
WO-2019016664-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF LENVATINIB BDR LIFESCIENCES PRIVATE LIMITED (IN) 2019-01-24 WO claimed
US-20140350301-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2014-11-27 US claimed
US-20130165696-A1 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2013-06-27 US claimed
EP-2588441-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR Actavis Group Ptc Ehf (IS) 2013-05-08 EP claimed
CN-103003231-A Novel method for preparing phenylcyclopropylamine derivatives and use thereof for preparing ticagrelor ACTAVIS GROUP PTC EHF 2013-03-27 CN claimed
WO-2012001531-A2 NOVEL PROCESSES FOR THE PREPARATION OF PHENYLCYCLOPROPYLAMINE DERIVATIVES AND USE THEREOF FOR PREPARING TICAGRELOR ACTAVIS GROUP PTC EHF (IS) 2012-01-05 WO claimed
US-12509418-B2 Chromophoric compounds and UV-absorbing compositions LYGG CORPORATION (US) 2025-12-30 US disclosed
EP-4642424-A1 CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS LYGG Corporation (US) 2025-11-05 EP disclosed
US-20250270164-A1 CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS LYGG CORPORATION 2025-08-28 US disclosed
CN-113874080-B IL-17A modulators and uses thereof 戴斯阿尔法公司 2024-09-27 CN disclosed
WO-2024145346-A1 CHROMOPHORIC COMPOUNDS AND UV-ABSORBING COMPOSITIONS LYGG CORPORATION (US) 2024-07-04 WO disclosed
CN-118103351-A Coronavirus inhibitors 共晶制药公司 2024-05-28 CN disclosed
WO-2011107585-A1 MORPHOLINO SUBSTITUTED UREA DERIVATIVES AS MTOR INHIBITORS CELLZOME LIMITED (GB) 2011-09-09 WO disclosed
US-20100168195-A1 DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS MERCK SHARP & DOHME CORP. 2010-07-01 US disclosed
EP-2142538-A1 DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS SCHERING CORPORATION (US) 2010-01-13 EP disclosed
US-20080254969-A1 Method of Preparing Substrates - Molecular Sieve Layers Complex Using Ultrasound and Apparatuses Used Therein Industry-University Cooperation Foundation Sogang University (KR) 2008-10-16 US disclosed
WO-2008100459-A1 DERIVATIVES AND ANALOGS OF CHROMAN AS FUNCTIONALLY SELECTIVE ALPHA2C ADRENORECEPTOR AGONISTS SCHERING CORPORATION (US) 2008-08-21 WO disclosed
WO-2006001648-A1 THE METHOD OFPREPAEING SUBSTRATES - MOLECULAR SIEVE LAYER COMPLEX USING ULTRASOUND AND APPARATUSES USED THEREIN Industry-University Cooperation Foundation Sogang University (KR) 2006-01-05 WO disclosed